
Shares of Coya Therapeutics Inc (NASDAQ:COYA) are trading higher Monday morning after the company provided an update regarding the development of a new treatment for Amyotrophic Lateral Sclerosis (ALS).
What To Know: The Houston-based clinical-stage biotechnology company is trending across social media platforms after revealing that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COYA 302.